Fuller N J, Bates C J, Hayes R J, Bradley A K, Greenwood A M, Tulloch S, Greenwood B M
Medical Research Council Dunn Nutrition Unit, Cambridge, U.K.
Ann Trop Paediatr. 1988 Jun;8(2):61-7. doi: 10.1080/02724936.1988.11748541.
Haematological indices and red cell folate levels (RCF) were measured during two annual surveys in a group of Gambian children aged 3 months-5 years who were participating in a trial of malaria chemoprophylaxis with Maloprim or chlorproguanil given with or without folate supplements. Chlorproguanil was given in an adult dose of 20 mg, Maloprim as one quarter or one half of the adult dose of 25 mg pyrimethamine and 100 mg dapsone. Antimalarials and folate supplements were given fortnightly. About 20% of children had low RCF levels (less than 100 ng/ml). Among children who did not receive supplementation with folate there were no significant differences in mean RCF levels between children who received Maloprim, chlorproguanil or placebo. Among children who received folate supplements, the mean RCF was significantly lower among those receiving chlorproguanil than among the controls. Mean RCF values were similar in children who received Maloprim or placebo. If chlorproguanil is used for malaria chemoprophylaxis in young children an age-related dose should be used.
在一项针对3个月至5岁冈比亚儿童的疟疾化学预防试验中,在两次年度调查期间测量了血液学指标和红细胞叶酸水平(RCF)。这些儿童参与了使用疟涤平或氯胍进行疟疾化学预防的试验,其中氯胍或添加或不添加叶酸补充剂。氯胍的成人剂量为20毫克,疟涤平的剂量为成人剂量(25毫克乙胺嘧啶和100毫克氨苯砜)的四分之一或二分之一。抗疟药和叶酸补充剂每两周服用一次。约20%的儿童红细胞叶酸水平较低(低于100纳克/毫升)。在未接受叶酸补充的儿童中,接受疟涤平、氯胍或安慰剂的儿童的平均红细胞叶酸水平无显著差异。在接受叶酸补充剂的儿童中,接受氯胍的儿童的平均红细胞叶酸水平显著低于对照组。接受疟涤平或安慰剂的儿童的平均红细胞叶酸值相似。如果在幼儿中使用氯胍进行疟疾化学预防,应使用与年龄相关的剂量。